Renowned computational biologist Janet Thornton discusses the potential of protein structure understanding in developing new ...
It started as a respiratory illness—or so everyone thought. But it quickly became apparent that SARS-CoV-2, the virus that ...
Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this ...
The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...
News Medical on MSN1d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainAnnouncing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...
Scientists have developed a simulation method incorporating quantum mechanics to model the electronic structure of nearly ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback